Medplus Share Price
(MEDPLUS)
Check the latest share price of Medplus, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 02 May 2025
NSE
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 9.27 % |
3 Month Return | + 5.06 % |
1 Year Return | + 20.08 % |
Market Stats | |
Previous Close | ₹806.15 |
Open | ₹793.05 |
Volume | 1.10L |
Upper Circuit | ₹967.35 |
Lower Circuit | ₹644.95 |
Market Cap | ₹9,584.48Cr |
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹9,584.48 Cr
Return on Equity (ROE)
0.75
PE Ratio (TTM)
72.2
Return on capital employed (ROCE)
1.13
Beta (LTM)
0.42
P/B Ratio
7.03
PEG Ratio
11.72
EPS (TTM)
5.49
Sector
Retail
Technical Analysis
Bullish
View Technical Analysis
Investing in Medplus is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Medplus or MEDPLUS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Medplus or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Medplus with just a few clicks!
Track how the P/E of Medplus has moved over time to understand valuation trends.
Medplus in the last 5 years
Lowest (62.62x)
March 18, 2025
Industry (-285.03x)
May 2, 2025
Today (72.20x)
May 2, 2025
Highest (263.63x)
March 17, 2023
Today’s Price to Earnings Ratio: 72.20x
Get updated buy, sell, and hold recommendations by analysts on Medplus.
based on 7 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Medplus. Average target price of ₹960
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Medplus.
Medplus price forecast by 7 analysts
Upside of19.89%
High
₹1160
Target
₹960.00
Low
₹900
Medplus target price ₹960, a slight upside of 19.89% compared to current price of ₹800.75. According to 7 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medplus revenue growth forecast
Expected growth rate Q1, FY2027:47.24%
Forecast
Actual
Including amortisation and stock based compensations
Medplus EPS growth forecast
EPS estimate Q1, FY2027:326.28%
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Medplus, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Medplus.
Medplus Health Services Ltd’s net profit jumped 234.23% since last year same period to ₹45.89Cr in the Q3 2024-2025. On a quarterly growth basis, Medplus Health Services Ltd has generated 18.46% jump in its net profits since last 3-months.
Read More about Earnings ResultsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Medplus.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 40.34% | 0.00 | |
Foreign Institutions | 15.61% | 0.00 | |
Mutual Funds | 21.59% | 0.00 | |
Retail Investors | 17.82% | 0.00 | |
Others | 4.64% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Medplus with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹9,584.48 Cr | -5.72% | 0.54 | ₹65 Cr | ₹5,624 Cr | |
NA | ₹98.91 Cr | 950.77% | 0.50 | NA | NA | |
NA | ₹74.74 Cr | 27.15% | 0.54 | NA | NA | |
NA | ₹40.15 Cr | -19.73% | 2.92 | -₹2,514 Cr | ₹2,993 Cr | |
NA | ₹23.54 Cr | 0.02% | 0.50 | NA | NA |
Latest news and events at one place to help you take investing decisions in Medplus.
Analyst Recommends Buy for Medplus Health Services - 15 Apr, 2025
MedPlus Subsidiary Faces Drug License Suspensions - 12 Apr, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, MEDPLUS stock has moved up by 19.5%
FII Holding Up
Foreign Institutions have increased holdings from 15.23% to 15.61% in Mar 2025 quarter
Profit Spike
Netprofit is up for the last 3 quarters, 14.36 Cr → 45.89 Cr (in ₹), with an average increase of 39.3% per quarter
Best in 1 Year
In the last 1 year, MEDPLUS has outperformed top 5 stocks with highest market-cap in Drug Retailers
MF Holding Up
Mutual Funds have increased holdings from 21.51% to 21.59% in Mar 2025 quarter
Against Peers
In the last 3 years, Muller & Phipps India Ltd has given 70.3% return, outperforming this stock by 89.0%
Retail Holding Down
Retail Investor have decreased holdings from 18.69% to 17.82% in Mar 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 1.58K Cr → 1.57K Cr (in ₹), with an average decrease of 0.9% per quarter
Promoter Holding Down
Promoters have decreased holdings from 40.39% to 40.34% in Mar 2025 quarter
Organisation | Medplus Health Services Ltd |
Headquarters | |
Industry | Retail |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Medplus.
Medplus Health Services Ltd share price today stands at ₹800.75, Open: ₹793.05, Previous Close: ₹806.15, High: ₹816.15, Low: ₹791.7, 52 Week High: ₹875.65, 52 Week Low: ₹616.
Today's traded volume of Medplus Health Services Ltd(MEDPLUS) is 1.10L.
Today's market capitalisation of Medplus Health Services Ltd(MEDPLUS) is ₹9,584.48 Cr.
Medplus Health Services Ltd (MEDPLUS) share price is ₹800.75. It is down -8.55% from its 52 Week High price of ₹875.65
Medplus Health Services Ltd (MEDPLUS) share price is ₹800.75. It is up 29.99% from its 52 Week Low price of ₹616